Ashton Thomas Private Wealth LLC Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ashton Thomas Private Wealth LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 884 shares of the medical equipment provider’s stock after selling 20 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Intuitive Surgical were worth $434,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. International Assets Investment Management LLC boosted its position in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares during the last quarter. Capital Research Global Investors purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at about $374,390,000. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.6% in the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after acquiring an additional 493,126 shares during the period. Strategic Financial Concepts LLC raised its holdings in shares of Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after purchasing an additional 265,461 shares during the last quarter. Finally, GQG Partners LLC bought a new position in Intuitive Surgical during the first quarter valued at approximately $99,523,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. This trade represents a 15.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amy L. Ladd sold 450 shares of the company’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the sale, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock worth $45,897,071 in the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 0.2 %

Shares of ISRG opened at $537.80 on Friday. Intuitive Surgical, Inc. has a 12-month low of $291.39 and a 12-month high of $544.38. The company has a market capitalization of $191.55 billion, a PE ratio of 86.46, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. The business’s 50 day moving average is $496.95 and its 200 day moving average is $455.65.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have commented on ISRG shares. Barclays lifted their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Piper Sandler reiterated an “overweight” rating and set a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Truist Financial raised their target price on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.